Ofloxacin intravenous. Compatibility with other antibacterial agents. 1991

R Janknegt, and T Stratermans, and J Cilissen, and J J Lohman, and P M Hooymans
Department of Clinical Pharmacy, Maasland Hospital, The Netherlands.

The physical and chemical compatibility of ofloxacin (infusion solution 100 ml = 200 mg) with amoxicillin, amoxicillin + clavulanic acid, flucloxacillin, tobramycin, gentamicin, clindamycin, vancomycin, ceftazidime and piperacillin was investigated. Upon admixture with flucloxacillin a precipitate formed between 7 and 24 hours. No other physical or chemical incompatibilities were observed with any of the other combinations. Ofloxacin may be safely combined with the tested antimicrobial drugs, except for flucloxacillin.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D011232 Chemical Precipitation The formation of a solid in a solution as a result of a chemical reaction or the aggregation of soluble substances into complexes large enough to fall out of solution. Precipitation, Chemical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D015242 Ofloxacin A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. DL-8280,DR-3355,Hoe-280,ORF-28489,Ofloxacin Hydrochloride,Ofloxacine,Ru-43280,Tarivid,DL 8280,DL8280,DR 3355,DR3355,Hoe 280,Hoe280,ORF 28489,ORF28489,Ru 43280,Ru43280

Related Publications

R Janknegt, and T Stratermans, and J Cilissen, and J J Lohman, and P M Hooymans
December 1990, Journal of chemotherapy (Florence, Italy),
R Janknegt, and T Stratermans, and J Cilissen, and J J Lohman, and P M Hooymans
January 1964, Giornale italiano della tubercolosi e delle malattie del torace,
R Janknegt, and T Stratermans, and J Cilissen, and J J Lohman, and P M Hooymans
June 1993, The Annals of pharmacotherapy,
R Janknegt, and T Stratermans, and J Cilissen, and J J Lohman, and P M Hooymans
March 1996, The Annals of pharmacotherapy,
R Janknegt, and T Stratermans, and J Cilissen, and J J Lohman, and P M Hooymans
January 1991, Chemotherapy,
R Janknegt, and T Stratermans, and J Cilissen, and J J Lohman, and P M Hooymans
February 1967, Lyon medical,
R Janknegt, and T Stratermans, and J Cilissen, and J J Lohman, and P M Hooymans
January 1991, Chemotherapy,
R Janknegt, and T Stratermans, and J Cilissen, and J J Lohman, and P M Hooymans
February 1992, Diagnostic microbiology and infectious disease,
R Janknegt, and T Stratermans, and J Cilissen, and J J Lohman, and P M Hooymans
July 1979, The Japanese journal of antibiotics,
R Janknegt, and T Stratermans, and J Cilissen, and J J Lohman, and P M Hooymans
October 2006, European journal of clinical investigation,
Copied contents to your clipboard!